Ninghua Tan

13PUBLICATIONS
14CO-AUTHORS
Biologically active moleculesPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 13, 2026
Discovery and engineering of bacterial P450s for C-14 hydroxylation in ent-kaurane diterpenoids.

Xiaoxu Lin, Zhixi Xiao, Xingwang Xu

|Sep 06, 2023
Programmable site-specific delivery of an alkaline phosphatase-activatable prodrug and a mitochondria-targeted cyclopeptide for combination therapy in colon cancer.

Huachao Chen, Yongrong Yao, Xing Zhao

|Sep 07, 2022
Discovery of Selenium-Containing STING Agonists as Orally Available Antitumor Agents.

Xi Feng, Lixia Pan, Zhiyu Qian

|May 11, 2022
TAK1 inhibition by natural cyclopeptide RA-V promotes apoptosis and inhibits protective autophagy in Kras-dependent non-small-cell lung carcinoma cells.

Jianhong Yang, Tao Yang, Wei Yan

|May 10, 2022
Anti-inflammatory activities of natural cyclopeptide RA-XII in colitis-associated colon cancer mouse model and its effect on gut microbiome.

Qianwen Lin, Mingyu Liu, Grace Gar-Lee Yue

|Oct 06, 2021
Authentication of three main commercial Pheretima based on amino acids analysis.

Qiao Liu, Qirui Bi, Ninghua Tan

Pageof 3

Frequent Collaborators

6 joint publications

Zhe Wang

2 joint publications

Jinlei Bian

2 joint publications

Xi Feng

2 joint publications

Zhiyu Li